196 related articles for article (PubMed ID: 25241892)
1. Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing.
Song JH; An N; Chatterjee S; Kistner-Griffin E; Mahajan S; Mehrotra S; Kraft AS
Oncogene; 2015 Jul; 34(28):3728-36. PubMed ID: 25241892
[TBL] [Abstract][Full Text] [Related]
2. The Pim protein kinases regulate energy metabolism and cell growth.
Beharry Z; Mahajan S; Zemskova M; Lin YW; Tholanikunnel BG; Xia Z; Smith CD; Kraft AS
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):528-33. PubMed ID: 21187426
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysfunction consistent with premature aging results from deletion of Pim kinases.
Din S; Konstandin MH; Johnson B; Emathinger J; Völkers M; Toko H; Collins B; Ormachea L; Samse K; Kubli DA; De La Torre A; Kraft AS; Gustafsson AB; Kelly DP; Sussman MA
Circ Res; 2014 Jul; 115(3):376-87. PubMed ID: 24916111
[TBL] [Abstract][Full Text] [Related]
4. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling axis for ROS generation during K-Ras-induced cellular transformation.
Park MT; Kim MJ; Suh Y; Kim RK; Kim H; Lim EJ; Yoo KC; Lee GH; Kim YH; Hwang SG; Yi JM; Lee SJ
Cell Death Differ; 2014 Aug; 21(8):1185-97. PubMed ID: 24632950
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Weinberg F; Hamanaka R; Wheaton WW; Weinberg S; Joseph J; Lopez M; Kalyanaraman B; Mutlu GM; Budinger GR; Chandel NS
Proc Natl Acad Sci U S A; 2010 May; 107(19):8788-93. PubMed ID: 20421486
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic K-Ras
Ito M; Tanuma N; Kotani Y; Murai K; Kondo A; Sumiyoshi M; Shima H; Matsuda S; Watanabe T
FEBS Open Bio; 2024 Apr; 14(4):545-554. PubMed ID: 38318686
[TBL] [Abstract][Full Text] [Related]
9. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
10. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N; Kraft AS; Kang Y
J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
[TBL] [Abstract][Full Text] [Related]
11. The essential role of PIM kinases in sarcoma growth and bone invasion.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Peregrina S; Garcia-Serelde B; Muñoz-Galvan S; Cañamero M; Carnero A
Carcinogenesis; 2012 Aug; 33(8):1479-86. PubMed ID: 22623646
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase.
Song JH; Singh N; Luevano LA; Padi SKR; Okumura K; Olive V; Black SM; Warfel NA; Goodrich DW; Kraft AS
Mol Cancer Ther; 2018 Dec; 17(12):2710-2721. PubMed ID: 30190422
[TBL] [Abstract][Full Text] [Related]
13. Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks.
Jinesh GG; Mokkapati S; Zhu K; Morales EE
Apoptosis; 2016 Nov; 21(11):1203-1213. PubMed ID: 27651368
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial ROS and radiation induced transformation in mouse embryonic fibroblasts.
Du C; Gao Z; Venkatesha VA; Kalen AL; Chaudhuri L; Spitz DR; Cullen JJ; Oberley LW; Goswami PC
Cancer Biol Ther; 2009 Oct; 8(20):1962-71. PubMed ID: 19738419
[TBL] [Abstract][Full Text] [Related]
15. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
[TBL] [Abstract][Full Text] [Related]
16. Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.
Chen JL; Limnander A; Rothman PB
Blood; 2008 Feb; 111(3):1677-85. PubMed ID: 18042805
[TBL] [Abstract][Full Text] [Related]
17. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis.
Hu Y; Lu W; Chen G; Wang P; Chen Z; Zhou Y; Ogasawara M; Trachootham D; Feng L; Pelicano H; Chiao PJ; Keating MJ; Garcia-Manero G; Huang P
Cell Res; 2012 Feb; 22(2):399-412. PubMed ID: 21876558
[TBL] [Abstract][Full Text] [Related]
18. Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts.
Muñoz-Félix JM; Fuentes-Calvo I; Cuesta C; Eleno N; Crespo P; López-Novoa JM; Martínez-Salgado C
J Cell Physiol; 2016 Oct; 231(10):2224-35. PubMed ID: 26873620
[TBL] [Abstract][Full Text] [Related]
19. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.
Warfel NA; Sainz AG; Song JH; Kraft AS
Mol Cancer Ther; 2016 Jul; 15(7):1637-47. PubMed ID: 27196781
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
